NCT02242799 Dolutegravir Interactions With Artemisinin-based Combination Therapies Status COMPLETED Phase PHASE1
NCT02237586 Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge Status COMPLETED Phase PHASE1
NCT02230579 Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02215707 A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses Status COMPLETED Phase PHASE1
NCT02213211 School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi Status COMPLETED Phase NA
NCT02211729 A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children Status COMPLETED Phase PHASE3
NCT02207816 An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa Status COMPLETED Phase PHASE3
NCT02206451 Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali Status COMPLETED Phase N/A
NCT02199977 Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector Status COMPLETED Phase NA
NCT02199951 Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania Status UNKNOWN Phase N/A
NCT02181088 A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5 Status COMPLETED Phase PHASE1
NCT02174978 Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults Status COMPLETED Phase PHASE1
NCT02174900 Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM) Status COMPLETED Phase PHASE2/PHASE3
NCT02168569 In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children Status COMPLETED Phase PHASE4
NCT02163447 Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infants Status COMPLETED Phase PHASE3
NCT02153996 Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States Status TERMINATED Phase N/A
NCT02149550 Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains Status COMPLETED Phase NA
NCT02132299 Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults Status COMPLETED Phase PHASE1